DUYGU KARA, Cafer Mutlu SARIKAŞ, Aslı DEMİR, MEHMET ALİ KAYĞIN, Ertekin Utku ÜNAL

Does heparin dosage calculated with ideal body weight reduce blood product use in open heart surgery?

The heparin regimen providing anticoagulation during cardiopulmonary bypass (CPB) is usually adapted to total body weight (TBW). However, this may cause redundant anticoagulation and increase perioperative bleeding, transfusion requirements and reoperation. We compared a heparin regimen based on ideal body weight (IBW) with the traditional regimen. After ethical approval, 100 adults undergoing elective cardiac surgery with CPB were recruited for the prospective, observational study in a tertiary hospital. Prior to CBP an unfractioned heparin dose was adjusted to 300 IU/kg based on TBW (Group TBW, n=50), or IBW (Group IBW, n=50). IBW was calculated using the Lorentz formula. The minimal Activated Coagulation Time (ACT) target value is 400 sec for CPB. Demographic data, cross-clamp and CPB durations, and Hb, Htc, platelet, PT, Aptt and fibrinogen values were similar between the groups (p>0.05). Heparin and total protamine doses were significantly higher in Group IBW (p

PDF

___

Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013;116:121022.

Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36-45.

Shuhaibar MN, Hargrove M, Millat MH, et al. How much heparin do we really need to go on pump? A rethink of current practices: European Journal of Cardio-thoracic Surgery. 2004:947-50.

Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 11th edition 2006 section 9-10, pp 1433-89

Lobato RL, Despotis GJ, Levy JH, et al. Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions. J Thorac Cardiovasc Surg. 2010;139:1665-6.

Levy JH, Sniecinski RM. Activated clotting times, heparin responses, and antithrombin: have we been wrong all these years? Anesth Analg. 2010;111:833-5.

Doty DB, Knot HW, Hoyt JI, et al. Heparin dose for accurate anticoagulation in cardiac surgery. J Cardiovasc Surg. 1979;20:597-604.

Bull BS, Huse WM, Brauer FS, et al. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685-9.

Lorentz PDFH. Ein neuer Konstitutionsindex. Klin Wochenschr. 1929;8:34851.

Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med Rev. 2007;21:37-48.

Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecularweight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest J. 2001;119:64-94.

Teoh K, Young E, Bradley C, et al. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass. Circulation. 1993;88:420-5.

Gravlee GP, Haddon WS, Rothberger HK, et al. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation. J Thorac Cardiovasc Surg. 1990;99:518-27.

Babka R, Colby C, El-Etr A, et al. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg. 1977;73:780-2.

Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36-45.

Runge M, Møller CH, Steinbrüchel DA. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study. J Extra Corpor Technol. 2009;41:10-4.

Dercksen SJ, Linssen GH. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times. Acta Anaesthesiol Belg. 1980;31:121-8.

Fromes Y, Daghildjian K, Caumartin L, et al. A comparison of low vs conventional-dose heparin for minimalcardiopulmonary bypass in coronary artery bypass grafting surgery. Anaesthesia. 2011;66:488-92.

Haas E, Fischer F, Levy F, et al. Identifying optimal heparin management during cardiopulmonary bypass in obese patients: A prospective observational comparative study. Eur J Anaesthesiol. 2016;33:408-16.

Chemoyl G. Clinical Pharmacokinetics of drugs in obesity. An up-date. Clin Pharmacokinet. 1993;25:103-14.

Barras M, Legg A. Drug dosing in obese adults. Aust Prescr. 2017;40(5):18993.

Jia Z, Tian G, Ren Y, et al. Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery. J Transl Med. 2015;13:45.

Boer C, Meesters MI, Milojevic M, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Task Force on Patient Blood Management for Adult Cardiac Surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA) J Cardiothorac Vasc Anesth. 2017;S1053-0770(17)30552-9.

Pretorius M, Scholl FG, McFarlane JA, et al. A pilot study indicating that bradykinin B-2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass. Clin Pharmacol Ther. 2005;78:477-85.

Miyashita T, Nakajima T, Hayashi Y, et al. Hemostatic effects of low-dose protamine following cardiopulmonary bypass. Am J Hematol. 2000;64:11215.

Mejak BL, Stammers A, Rauch E, et al. A retrospective study on perfusion incidents and safety devices. Perfusion. 2000;15:51–61.

Charriere JM, Pelissie J, Verd C, et al. Survey: Retrospective survey of monitoring/safety devices and incidents of cardiopulmonary bypass for cardiac surgery in France. J Extra Corpor Technol. 2007;39:142-57.

Babka R, Colby C, El-Etr A, et al. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg. 1977;73:780-82.

Chun DH, Baik SW, Kim SY, et al. Heparin responsiveness during off-pump coronary artery bypass graft surgery: Predictors and clinical implications. Acta Pharmacol Sin. 2011;32:133-38.

Chakravarthy M, Prabhakumar D, Thimmannagowda P, et al. Comparison of Two Doses of Heparin on Outcome in Off-pump Coronary Artery Bypass Surgery Patients: A Prospective Randomized Control Study. Ann Card Anaesth. 2017;20:8-13.